Apolipoprotein b/apolipoprotein A1 ratio
Apolipoprotein b/apolipoprotein A1 ratio has been studied in 1 paper since 2026: 1 observational study in people; 1 in the past year. The newest paper, Jun 17, 2026: “Association of the apolipoproteins with retinal arteriosclerosis in a health examination population”.
1 paper studies it1 findingUpdated
See all 1 papers on apolipoprotein b/apolipoprotein A1 ratio
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“both ApoB (per 1-SD increase: OR 1.12, 95% CI 1.01-1.24) and ApoB/ApoA1 ratio (per 1-SD increase: OR 1.14, 95% CI 1.03-1.27) remained independently associated with retinal arteriosclerosis”
- 1 lab in 1 country
- Funder: National Key Research and Development Program of China
- Humans1
What is apolipoprotein b/apolipoprotein A1 ratio linked with?
1Studies link apolipoprotein b/apolipoprotein A1 ratio with 1 measure, most often retinal arteriosclerosis (1 study).
Retinal arteriosclerosis
upin humans1OR 1.14
1 study
Retinal arteriosclerosis
upin humans1OR 1.14
Apolipoprotein b/apolipoprotein A1 ratio is associated with retinal arteriosclerosis in humans (OR 1.14 per 1-SD increase, 95% CI 1.03-1.27).
“both ApoB (per 1-SD increase: OR 1.12, 95% CI 1.01-1.24) and ApoB/ApoA1 ratio (per 1-SD increase: OR 1.14, 95% CI 1.03-1.27) remained independently associated with retinal arteriosclerosis”
Humansfully adjusted models for demographic, lifestyle, clinical and laboratory confounders; per 1-SD increase
Association of the apolipoproteins with retinal arteriosclerosis in a health examination population
Frontiers in cardiovascular medicine